Idioma:

Acellular anti-pertussis vaccine

Bégué, P ; Grimpel, E ; Baron, S

Bulletin de la Societe de pathologie exotique (1990), 1991, Vol.84 (5 Pt 5), p.859-865 [Periódico revisado por pares]

Sem texto completo

Citações Citado por

Título:
Acellular anti-pertussis vaccine
Autor: Bégué, P ; Grimpel, E ; Baron, S
Assuntos: Adolescent ; Antigens, Bacterial - immunology ; Bacterial Toxins - immunology ; Bordetella pertussis - immunology ; Child ; Child, Preschool ; Global Health ; Humans ; Immunization, Secondary ; Infant ; Pertussis Vaccine - adverse effects ; Pertussis Vaccine - standards ; Whooping Cough - prevention & control
É parte de: Bulletin de la Societe de pathologie exotique (1990), 1991, Vol.84 (5 Pt 5), p.859-865
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Descrição: Since several years, pertussis has increased especially in non-immunized young infants under 6 months of age, in countries where pertussis-immunization is in widespread use. The whole-cellular pertussis vaccine so far used in these countries is not well tolerated, has been indicted in adverse neurological complications, and offers significant but temporary protection partially because of the absence of late booster-shots. The necessity to improve vaccine protection has justified the development of much better tolerated acellular pertussis vaccines thus allowing repeated booster-shots. Its safety and duration of protection are still under evaluation, but preliminary results are promising.
Editor: France
Idioma: Francês

Links

Voltar para lista de resultados